纳米医学诱导的癌症治疗中的编程细胞死亡:机制和前景
Lin Luobin1,2, He Wanxin1, Guo Yingxin1
1School of Health Sciences, Guangzhou Xinhua University, 19 Huamei Road, Tianhe District, Guangzhou, 510520, China.
Cell death discovery
|August 29, 2024
概括
纳米医学精确地通过激活编程细胞死亡 (PCD) 途径,如亡和亡来向癌细胞. 与传统化疗相比,这种方法提高了治疗效率,减少了副作用.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 细胞生物学 细胞生物学
背景情况:
- 编程细胞死亡 (PCD) 途径对于癌症的进展和治疗至关重要.
- PCD的失调会导致细胞生长失控和耐治疗性.
- 纳米医学提供有针对性的药物输送,以改善癌症治疗结果.
研究的目的:
- 探索PCD机制在癌症中的作用.
- 审查纳米医学策略,以激活癌细胞中的PCD通路.
- 突出纳米技术在增强癌症治疗特异性和降低毒性方面的潜力.
主要方法:
- 详细审查各种PCD途径 (亡,自,亡).
- 分析纳米医药方法用于有针对性的输送和PCD诱导.
- 检查表明治疗效率提高和副作用减少的研究.
主要成果:
- 纳米医学能够精确地准癌细胞,激活特定的PCD通路.
- 纳米药物对PCD通路的有针对性的激活可以减少对健康组织的损伤.
- 这种方法提高了治疗效率,并最大限度地减少了传统疗法的不良影响.
结论:
- 纳米技术和有针对性的PCD激活之间的协同作用为改善癌症治疗提供了一个有希望的战略.
- 纳米医药介导的PCD诱导可以导致更有效,更少毒性的癌症疗法.
- 这种创新方法预示着瘤学的新时代,改善了患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K


